These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 32498072

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cytologic evaluation of low grade transitional cell carcinoma and instrument artifact in bladder washings.
    Chu YC, Han JY, Han HS, Kim JM, Suh JK.
    Acta Cytol; 2002; 46(2):341-8. PubMed ID: 11917583
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Integrated immunohistochemical and molecular analysis improves diagnosis of high-grade carcinoma in the urinary bladder of patients with prior radiation therapy for prostate cancer.
    Chan E, Garg K, Stohr BA.
    Mod Pathol; 2020 Sep; 33(9):1802-1810. PubMed ID: 32313185
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Association of adenocarcinoma of the prostate with transitional carcinoma of the bladder].
    de Boccard GA, Chatelanat F, Graber P.
    Helv Chir Acta; 1985 Sep; 52(3-4):533-4. PubMed ID: 4066384
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Grade 2 urethroprostatic papillary urothelial carcinoma with positive urinary cytology.
    Mincione GP, Di Cello V, Nigi L, Durval A, Saltutti C.
    J Urol; 1985 Jun; 133(6):1038-9. PubMed ID: 3999205
    [Abstract] [Full Text] [Related]

  • 12. Current status of cancers of the bladder and prostate.
    Jacobs SC, Campbell EW, Naslund MJ.
    Trans Assoc Life Insur Med Dir Am; 1991 Jun; 74():144-51. PubMed ID: 1853521
    [No Abstract] [Full Text] [Related]

  • 13. 9p21 index as estimated by dual-color fluorescence in situ hybridization is useful to predict urothelial carcinoma recurrence in bladder washing cytology.
    Kawauchi S, Sakai H, Ikemoto K, Eguchi S, Nakao M, Takihara H, Shimabukuro T, Furuya T, Oga A, Matsuyama H, Takahashi M, Sasaki K.
    Hum Pathol; 2009 Dec; 40(12):1783-9. PubMed ID: 19733894
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Poorly differentiated adenocarcinomas of prostate versus high-grade urothelial carcinoma of the bladder: a diagnostic dilemma with immunohistochemical evaluation of 2 cases.
    Martínez-Rodríguez M, Ramos D, Soriano P, Subramaniam M, Navarro S, Llombart-Bosch A.
    Int J Surg Pathol; 2007 Apr; 15(2):213-8. PubMed ID: 17478786
    [Abstract] [Full Text] [Related]

  • 17. Micropapillary variant of transitional cell carcinoma of the urinary bladder: a report of three cases with cytologic diagnosis in urine specimens.
    Ylagan LR, Humphrey PA.
    Acta Cytol; 2001 Apr; 45(4):599-604. PubMed ID: 11480725
    [Abstract] [Full Text] [Related]

  • 18. Transitional cell carcinoma of the prostate.
    Algaba F, Santaularia JM, Lamas M, Ayala G.
    Eur Urol; 1985 Apr; 11(2):87-90. PubMed ID: 3891355
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.